HCG703.50

Healthcare Global Enterprises Ltd.

· Pharma & Health
₹ CrorePeersAPOLLOHOSPFORTISRAINBOWJLHLCORONAMARKSANSMETROPOLISPARKHOSPSMcap ₹10,123 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Total Debt672.81,002.2910.4910.4
Net Debt400.2766.4374.4374.4
Total Debt/Equity0.781.010.650.65
Net Debt/Equity0.460.770.270.27
Total Debt/EBITDA2.042.591.951.95
Net Debt/EBITDA1.211.980.800.78
Interest Coverage (EBIT/Interest)1.431.141.261.26
Total Debt/Total Capital %43.7550.3139.2339.23
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.